Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Condition:   Surgical Site Infection Interventions:   Drug: 4% Chlorhexidine Gluconate;   Drug: 2% Mupirocin;   Drug: Soap Without Antiseptic Properties (Placebo);   Drug: Placebo Nasal Ointment Sponsors:   University of California, Irvine;   University of California, Davis;   University of California, San Francisco;   University of Massachusetts, Amherst Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

A randomized, placebo-controlled, double-blinded trial of MRSA throat carriage treatment, with either standard decolonization alone or in combination with oral clindamycin
DiscussionDue to the lack of consistent scientific evidence of clindamycin ’s effect in MRSA decolonization and the worldwide urgent need to reduce the use of antibiotics, we judged that a 30% increase in the decolonization success rate in carriers treated with clindamycin is appropriate to justify prescribing clindamycin as part of the decolonization treatment of asympt omatic MRSA carriers.Trial registrationEudraCT number 2019-002631-29 (Source: Trials)
Source: Trials - June 16, 2022 Category: Research Source Type: clinical trials

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection
Condition:   Peritoneal Dialysis-related Infection Interventions:   Drug: Mupirocin;   Drug: Gentamicin Sponsors:   Phramongkutklao College of Medicine and Hospital;   Silpakorn University Faculty of Pharmacy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2022 Category: Research Source Type: clinical trials